bis(sulfosuccinimidyl)suberate has been researched along with glucose, (beta-d)-isomer in 1 studies
Studies (bis(sulfosuccinimidyl)suberate) | Trials (bis(sulfosuccinimidyl)suberate) | Recent Studies (post-2010) (bis(sulfosuccinimidyl)suberate) | Studies (glucose, (beta-d)-isomer) | Trials (glucose, (beta-d)-isomer) | Recent Studies (post-2010) (glucose, (beta-d)-isomer) |
---|---|---|---|---|---|
119 | 0 | 28 | 21,956 | 883 | 10,747 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Friedrichson, T; Kurzchalia, TV; Masserini, M; Pitto, M; Schulz, JB; Simons, M | 1 |
1 other study(ies) available for bis(sulfosuccinimidyl)suberate and glucose, (beta-d)-isomer
Article | Year |
---|---|
Exogenous administration of gangliosides displaces GPI-anchored proteins from lipid microdomains in living cells.
Topics: Animals; Carrier Proteins; CD55 Antigens; Cell Line; CHO Cells; Cricetinae; Cross-Linking Reagents; Dogs; Fluorescent Antibody Technique; Folate Receptors, GPI-Anchored; G(M1) Ganglioside; Gangliosides; Glucosides; Glycosylphosphatidylinositols; Growth Hormone; Membrane Lipids; Membrane Proteins; Orthomyxoviridae; Receptors, Cell Surface; Succinimides | 1999 |